Article

Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.

Institute of Biomedicine, University of Gothenburg, SE-405 30 Gothenburg, Sweden.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 08/2010; 107(35):15595-600. DOI: 10.1073/pnas.1001740107
Source: PubMed

ABSTRACT Soluble oligomeric aggregates of the amyloid-beta peptide (Abeta) have been implicated in the pathogenesis of Alzheimer's disease (AD). Although the conformation adopted by Abeta within these aggregates is not known, a beta-hairpin conformation is known to be accessible to monomeric Abeta. Here we show that this beta-hairpin is a building block of toxic Abeta oligomers by engineering a double-cysteine mutant (called Abetacc) in which the beta-hairpin is stabilized by an intramolecular disulfide bond. Abeta(40)cc and Abeta(42)cc both spontaneously form stable oligomeric species with distinct molecular weights and secondary-structure content, but both are unable to convert into amyloid fibrils. Biochemical and biophysical experiments and assays with conformation-specific antibodies used to detect Abeta aggregates in vivo indicate that the wild-type oligomer structure is preserved and stabilized in Abetacc oligomers. Stable oligomers are expected to become highly toxic and, accordingly, we find that beta-sheet-containing Abeta(42)cc oligomers or protofibrillar species formed by these oligomers are 50 times more potent inducers of neuronal apoptosis than amyloid fibrils or samples of monomeric wild-type Abeta(42), in which toxic aggregates are only transiently formed. The possibility of obtaining completely stable and physiologically relevant neurotoxic Abeta oligomer preparations will facilitate studies of their structure and role in the pathogenesis of AD. For example, here we show how kinetic partitioning into different aggregation pathways can explain why Abeta(42) is more toxic than the shorter Abeta(40), and why certain inherited mutations are linked to protofibril formation and early-onset AD.

0 Followers
 · 
163 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The progressive neurodegeneration in Alzheimer's disease is believed to be linked to the presence of prefibrillar aggregates of the amyloid-β (Aβ) peptide in the brain. The exact role of these aggregates in the disease pathology is, however, still an open question. Any mechanism by which oligomeric Aβ may cause damage to neuronal cells must, in one way or another, involve interactions with other molecules. Here, we identify proteins in human serum and cerebrospinal fluid that bind to stable protofibrils formed by an engineered variant of Aβ42 (Aβ42CC). We find that the protofibrils attract a substantial number of protein binding partners. Many of the 101 identified proteins are involved in lipid transport and metabolism, the complement system or in hemostasis. Binding of representative proteins from all these groups with micromolar affinity was confirmed using surface plasmon resonance. In addition, binding of apolipoprotein E to the protofibrils with nanomolar affinity was demonstrated. We also find that aggregation of Aβ enhances protein binding, as lower amounts of proteins bind monomeric Aβ. Proteins that bind to Aβ protofibrils might contribute to biological effects that these aggregates are involved in. Our results therefore suggest that improved understanding of the mechanisms by which Aβ causes cytotoxicity and neurodegeneration might be gained from studies carried out in biologically relevant matrices in which Aβ-binding proteins are present.
    ACS Chemical Biology 12/2014; DOI:10.1021/cb5008663 · 5.36 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Many factors are known to influence the oligomerisation, fibrillation and amyloid formation of the Aβ peptide that is associated with Alzheimer's Disease. Other proteins that are present when Aβ peptides deposit in vivo, are likely to have an effect on these aggregation processes. In order to separate specific vs. broad-spectrum effects of proteins on Aβ aggregation, we tested a series of proteins not reported to have chaperone activity: catalase, pyruvate kinase, albumin, lysozyme, α-lactalbumin, and β-lactoglobulin. All tested proteins suppressed the fibrillation of Alzheimer's Aβ(1-40) peptide at sub-stoichiometric ratios, albeit some more effectively than others. All proteins bound non-specifically to Aβ, stabilised its random coils and reduced its cytotoxicity. Surprisingly, pyruvate kinase and catalase were at least as effective as known chaperones in inhibiting Aβ aggregation. We propose general mechanisms for the broad-spectrum inhibition Aβ fibrillation by proteins. The mechanisms we discuss are significant for prognostics and perhaps even for prevention and treatment of Alzheimer's Disease.
    Journal of Biological Chemistry 08/2014; 289(40). DOI:10.1074/jbc.M114.574947 · 4.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A critical step of β-amyloid fibril formation is fibril elongation in which amyloid-β monomers undergo structural transitions to fibrillar structures upon their binding to fibril tips. The atomic detail of the structural transitions remains poorly understood. Computational characterization of the structural transitions is limited so far to short Aβ segments (5-10 aa) owing to the long timescale of Aβ fibril elongation. To overcome the computational timescale limit, we combined a hybrid-resolution model with umbrella sampling and replica exchange molecular dynamics and performed altogether ∼1.3 ms of molecular dynamics simulations of fibril elongation for Aβ17-42. Kinetic network analysis of biased simulations resulted in a kinetic model which encompasses all Aβ segments essential for fibril formation. The model not only reproduces key properties of fibril elongation measured in experiments, including Aβ binding affinity, activation enthalpy of Aβ structural transitions and a large timescale gap (τlock/τdock = 103-104) between Aβ binding and its structural transitions, but also reveals detailed pathways involving structural transitions not seen before, namely fibril formation both in hydrophobic regions L17-A21 and G37-A42 preceding fibril formation in hydrophilic region E22-A30. Moreover, the model identifies as important kinetic intermediates strand-loop-strand (SLS) structures of Aβ monomers, long suspected to be related to fibril elongation. The kinetic model suggests further that fibril elongation arises faster at the fibril tip with exposed L17-A21, rather than at the other tip, explaining thereby unidirectional fibril growth observed previously in experiments.
    Journal of the American Chemical Society 08/2014; 136(35). DOI:10.1021/ja507002p · 11.44 Impact Factor

Full-text (2 Sources)

Download
65 Downloads
Available from
May 28, 2014